Premium
Local effects of recombinant rat interleukin‐6 on the peripheral nervous system
Author(s) -
Zou L. P.,
Quiding C.
Publication year - 1999
Publication title -
immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.297
H-Index - 133
eISSN - 1365-2567
pISSN - 0019-2805
DOI - 10.1046/j.1365-2567.1999.00808.x
Subject(s) - endoneurium , inflammation , sciatic nerve , perineurium , peripheral nervous system , central nervous system , pathology , cytokine , immunology , nervous system , neurogenic inflammation , medicine , cd8 , immune system , biology , endocrinology , anatomy , neuroscience , peripheral nerve , substance p , neuropeptide , receptor
Interleukin‐6 (IL‐6) is a multifunctional cytokine with a broad range of activities and can affect a variety of target cells or systems in multiple ways. However, there is currently no consensus on how IL‐6 directly affects the peripheral nervous tissue. We performed histopathological and immunohistochemical analyses to investigate the direct effects of recombinant rat IL‐6 (rrIL‐6) following its intraneural injection into the sciatic nerve of adult Lewis rats. One day after injection, a large number of macrophages, major histocompatibility complex (MHC) class II positive cells, and CD4 + and CD8 + T cells appeared within the perineurium and endoneurium. From day 4 to day 7 after injection, we observed a gradual increase of inflammation and demyelination. On day 7, demyelination affected more than 80% of nerve fibres. In contrast, in the sterile phosphate‐buffered saline (PBS)‐injected control group, lower inflammation and fewer demyelinating nerve fibres were observed on days 4 and 7. Thus, intraneural injection of rrIL‐6 into the sciatic nerve induces high inflammation and severe demyelination. This study improves our understanding of the effector mechanisms underlying inflammation and demyelination and identifies IL‐6 as an essential mediator of inflammation and demyelination in the peripheral nervous system after local administration.